-
Product Insights
New![]()
Odros ET Solar Park
Odros ET Solar Park is a solar PV project located in Inner Mongolia, China. The project is owned and developed by ET Solar New Energy Co Ltd. The project came online in 2013. Empower your strategies with our Odros ET Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
New![]()
Gefell-ET Solar Park
Gefell-ET Solar Park is a solar PV project located in Thuringia, Germany. The project is owned by Wattner AG and was developed by HDS Schilling GmbH. The project came online in 2012. Empower your strategies with our Gefell-ET Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Cheniers et Villers-Le-Chateau
Cheniers et Villers-Le-Chateau is an Onshore Wind project located in Grand Est, France. The project is owned by Valorem SAS and is developed by Cheniers Energies SARL. The project is currently under construction. Empower your strategies with our Cheniers et Villers-Le-Chateau report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
New![]()
Tille et Venelle Wind Farm
Tille et Venelle Wind Farm is an Onshore Wind project located in Bourgogne-Franche-Comte, France. The project is owned by The Renewables Infrastructure Group Ltd and was developed by Velocita Energies. The project came online in 2020. Empower your strategies with our Tille et Venelle Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
New![]()
La Capelle-et-Masmolène Solar PV Park
La Capelle-et-Masmolène Solar PV Park is a solar PV project located in Occitanie, France. The project was developed by Arkolia Energies SAS. The project came online in 2016. Empower your strategies with our La Capelle-et-Masmolène Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ET-150 in Relapsed Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ET-150 in Relapsed Multiple Myeloma Drug Details: ET-150 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ET-150 in Refractory Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ET-150 in Refractory Multiple Myeloma Drug Details: ET-150 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Selinexor in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug Details: Selinexor (Xpovio, Nexpovio) is an antineoplastic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Jaktinib Hydrochloride in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Jaktinib Hydrochloride in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug Details: Jaktinib is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ezobresib in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ezobresib in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug Details: Ezobresib (BMS-986158) is under development for the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.